Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-21 @ 7:09 AM
Study NCT ID:
NCT02471404
Status:
COMPLETED
Last Update Posted:
2019-03-26
First Post:
2015-06-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-11
First Submit QC Date:
None
Study First Post Date:
2015-06-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-13
Results First Submit QC Date:
None
Results First Post Date:
2019-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-22
Last Update Post Date:
2019-03-26
Last Update Post Date Type:
ACTUAL